Cargando…

Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial

PURPOSE: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. PATIENTS AND METHODS: 172 adult patients unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Xiwen, Chen, Xuehan, Zheng, Xuemei, Lyu, Hongyao, Chen, Jie, Yan, Ai, Liu, Qi, Li, Shiqi, Zhang, Yamei, Wang, Ting, Duan, Guangyou, Huang, He
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300329/
https://www.ncbi.nlm.nih.gov/pubmed/37389042
http://dx.doi.org/10.1016/j.heliyon.2023.e17061
_version_ 1785064563926892544
author Zhu, Xiwen
Chen, Xuehan
Zheng, Xuemei
Lyu, Hongyao
Chen, Jie
Yan, Ai
Liu, Qi
Li, Shiqi
Zhang, Yamei
Wang, Ting
Duan, Guangyou
Huang, He
author_facet Zhu, Xiwen
Chen, Xuehan
Zheng, Xuemei
Lyu, Hongyao
Chen, Jie
Yan, Ai
Liu, Qi
Li, Shiqi
Zhang, Yamei
Wang, Ting
Duan, Guangyou
Huang, He
author_sort Zhu, Xiwen
collection PubMed
description PURPOSE: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. PATIENTS AND METHODS: 172 adult patients undergoing elective colonoscopy were randomized to receive intravenous propofol at 2 mg/kg (group P) or alfentanil at 10 μg/kg (group A); 40 healthy volunteers were included in the blank group. Cognitive function was considered the primary outcome and was measured using five neuropsychological tests before sedation and discharge. The z-score method was used to determine cognitive dysfunction according to z-score >1.96 in two types of neuropsychological tests. Other outcomes included discharge time, vital signs, associated adverse events during colonoscopy, and the satisfaction level of patients and endoscopic physicians. RESULTS: 164 patients (78 in group A and 86 in group P) completed the study protocol. At discharge, the incidence of cognitive dysfunction in group P was 23% and was significantly lower in the alfentanil group (2.5%), with a relative risk of 0.11 (95% confidence interval: 0.03–0.46, P < 0.001). The incidence of hypotension in group A was lower than that in group P (3.8% vs 22.1%, relative risk = 0.17 [95% confidence interval: 0.05–0.46, P = 0.001]), and the discharge time in group A was shorter than that in group P (5 [(Rutter and et al., 2016; Zhang and et al., 2013; Hirsh and et al., 2006; Zhou and et al., 2021; Singh and et al., 2008; Ko and et al., 2010; Sargin et al., 2019) 3–93–9 vs 13 [(Ekmekci and et al., 2017; Eberl and et al., 2012; Eberl and et al., 2014; N'Kaoua and et al., 2002; Chung et al., 1995; Berger and et al., 2019; Quan and et al., 2019; Deng and et al., 2021; Gualtieri and Johnson, 2006) 10–1810–18 min, P < 0.001). CONCLUSION: For patients undergoing colonoscopy, single-use alfentanil causes less damage to postoperative cognitive function, less risk of hypotension, and shorter discharge time than propofol.
format Online
Article
Text
id pubmed-10300329
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-103003292023-06-29 Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial Zhu, Xiwen Chen, Xuehan Zheng, Xuemei Lyu, Hongyao Chen, Jie Yan, Ai Liu, Qi Li, Shiqi Zhang, Yamei Wang, Ting Duan, Guangyou Huang, He Heliyon Research Article PURPOSE: Colonoscopy is often accompanied by short-term postoperative cognitive decline. We aimed to explore whether single-use alfentanil for patients undergoing elective colonoscopy could reduce cognitive impairment at discharge compared with propofol. PATIENTS AND METHODS: 172 adult patients undergoing elective colonoscopy were randomized to receive intravenous propofol at 2 mg/kg (group P) or alfentanil at 10 μg/kg (group A); 40 healthy volunteers were included in the blank group. Cognitive function was considered the primary outcome and was measured using five neuropsychological tests before sedation and discharge. The z-score method was used to determine cognitive dysfunction according to z-score >1.96 in two types of neuropsychological tests. Other outcomes included discharge time, vital signs, associated adverse events during colonoscopy, and the satisfaction level of patients and endoscopic physicians. RESULTS: 164 patients (78 in group A and 86 in group P) completed the study protocol. At discharge, the incidence of cognitive dysfunction in group P was 23% and was significantly lower in the alfentanil group (2.5%), with a relative risk of 0.11 (95% confidence interval: 0.03–0.46, P < 0.001). The incidence of hypotension in group A was lower than that in group P (3.8% vs 22.1%, relative risk = 0.17 [95% confidence interval: 0.05–0.46, P = 0.001]), and the discharge time in group A was shorter than that in group P (5 [(Rutter and et al., 2016; Zhang and et al., 2013; Hirsh and et al., 2006; Zhou and et al., 2021; Singh and et al., 2008; Ko and et al., 2010; Sargin et al., 2019) 3–93–9 vs 13 [(Ekmekci and et al., 2017; Eberl and et al., 2012; Eberl and et al., 2014; N'Kaoua and et al., 2002; Chung et al., 1995; Berger and et al., 2019; Quan and et al., 2019; Deng and et al., 2021; Gualtieri and Johnson, 2006) 10–1810–18 min, P < 0.001). CONCLUSION: For patients undergoing colonoscopy, single-use alfentanil causes less damage to postoperative cognitive function, less risk of hypotension, and shorter discharge time than propofol. Elsevier 2023-06-12 /pmc/articles/PMC10300329/ /pubmed/37389042 http://dx.doi.org/10.1016/j.heliyon.2023.e17061 Text en © 2023 The Authors. Published by Elsevier Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Research Article
Zhu, Xiwen
Chen, Xuehan
Zheng, Xuemei
Lyu, Hongyao
Chen, Jie
Yan, Ai
Liu, Qi
Li, Shiqi
Zhang, Yamei
Wang, Ting
Duan, Guangyou
Huang, He
Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_full Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_fullStr Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_full_unstemmed Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_short Effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: A randomized controlled trial
title_sort effects of single-use alfentanil versus propofol on cognitive functions after colonoscopy: a randomized controlled trial
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300329/
https://www.ncbi.nlm.nih.gov/pubmed/37389042
http://dx.doi.org/10.1016/j.heliyon.2023.e17061
work_keys_str_mv AT zhuxiwen effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT chenxuehan effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT zhengxuemei effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT lyuhongyao effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT chenjie effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT yanai effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT liuqi effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT lishiqi effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT zhangyamei effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT wangting effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT duanguangyou effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial
AT huanghe effectsofsingleusealfentanilversuspropofoloncognitivefunctionsaftercolonoscopyarandomizedcontrolledtrial